368 related articles for article (PubMed ID: 37111404)
41. Gut dysbiosis and age-related neurological diseases; an innovative approach for therapeutic interventions.
Holmes A; Finger C; Morales-Scheihing D; Lee J; McCullough LD
Transl Res; 2020 Dec; 226():39-56. PubMed ID: 32755639
[TBL] [Abstract][Full Text] [Related]
42. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.
Rizzetto L; Fava F; Tuohy KM; Selmi C
J Autoimmun; 2018 Aug; 92():12-34. PubMed ID: 29861127
[TBL] [Abstract][Full Text] [Related]
43. Hematopoietic Cell Transplantation Rescues Inflammatory Bowel Disease and Dysbiosis of Gut Microbiota in XIAP Deficiency.
Ono S; Takeshita K; Kiridoshi Y; Kato M; Kamiya T; Hoshino A; Yanagimachi M; Arai K; Takeuchi I; Toita N; Imamura T; Sasahara Y; Sugita J; Hamamoto K; Takeuchi M; Saito S; Onuma M; Tsujimoto H; Yasui M; Taga T; Arakawa Y; Mitani Y; Yamamoto N; Imai K; Suda W; Hattori M; Ohara O; Morio T; Honda K; Kanegane H
J Allergy Clin Immunol Pract; 2021 Oct; 9(10):3767-3780. PubMed ID: 34246792
[TBL] [Abstract][Full Text] [Related]
44. Treg-associated monogenic autoimmune disorders and gut microbial dysbiosis.
Liu Y; Freeborn J; Armbrister SA; Tran DQ; Rhoads JM
Pediatr Res; 2022 Jan; 91(1):35-43. PubMed ID: 33731809
[TBL] [Abstract][Full Text] [Related]
45. Role of intestinal microbiota and metabolites on gut homeostasis and human diseases.
Lin L; Zhang J
BMC Immunol; 2017 Jan; 18(1):2. PubMed ID: 28061847
[TBL] [Abstract][Full Text] [Related]
46. Possibilities of therapeutic manipulation of the gut microbiota.
Drastich P; Bajer L; Kverka M
Vnitr Lek; 2018; 64(6):665-671. PubMed ID: 30223665
[TBL] [Abstract][Full Text] [Related]
47. Microbiota medicine: towards clinical revolution.
Gebrayel P; Nicco C; Al Khodor S; Bilinski J; Caselli E; Comelli EM; Egert M; Giaroni C; Karpinski TM; Loniewski I; Mulak A; Reygner J; Samczuk P; Serino M; Sikora M; Terranegra A; Ufnal M; Villeger R; Pichon C; Konturek P; Edeas M
J Transl Med; 2022 Mar; 20(1):111. PubMed ID: 35255932
[TBL] [Abstract][Full Text] [Related]
48. Good girl goes bad: Understanding how gut commensals cause disease.
Dey P
Microb Pathog; 2024 May; 190():106617. PubMed ID: 38492827
[TBL] [Abstract][Full Text] [Related]
49. Clinical heterogeneity in families with multiple cases of inborn errors of immunity.
Delavari S; Rasouli SE; Fekrvand S; Chavoshzade Z; Mahdaviani SA; Shirmast P; Sharafian S; Sherkat R; Momen T; Aleyasin S; Ahanchian H; Sadeghi-Shabestari M; Esmaeilzadeh H; Barzamini S; Tarighatmonfared F; Salehi H; Esmaeili M; Marzani Z; Fathi N; Abolnezhadian F; Rad MK; Saeedi-Boroujeni A; Shirkani A; Bagheri Z; Salami F; Shad TM; Marzbali MY; Mojtahedi H; Razavi A; Tavakolinia N; Cheraghi T; Tavakol M; Shafiei A; Behniafard N; Ebrahimi SS; Sepahi N; Ghaneimoghadam A; Rezaei A; Kalantari A; Abolhassani H; Rezaei N
Clin Immunol; 2024 Feb; 259():109896. PubMed ID: 38184287
[TBL] [Abstract][Full Text] [Related]
50. Gut microbiome a promising target for management of respiratory diseases.
Trivedi R; Barve K
Biochem J; 2020 Jul; 477(14):2679-2696. PubMed ID: 32726437
[TBL] [Abstract][Full Text] [Related]
51. Diagnostic Challenges in Patients with Inborn Errors of Immunity with Different Manifestations of Immune Dysregulation.
Pieniawska-Śmiech K; Pasternak G; Lewandowicz-Uszyńska A; Jutel M
J Clin Med; 2022 Jul; 11(14):. PubMed ID: 35887984
[TBL] [Abstract][Full Text] [Related]
52. Granulomatous inflammation in inborn errors of immunity.
Sacco KA; Gazzin A; Notarangelo LD; Delmonte OM
Front Pediatr; 2023; 11():1110115. PubMed ID: 36891233
[TBL] [Abstract][Full Text] [Related]
53. Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis.
Tojo R; Suárez A; Clemente MG; de los Reyes-Gavilán CG; Margolles A; Gueimonde M; Ruas-Madiedo P
World J Gastroenterol; 2014 Nov; 20(41):15163-76. PubMed ID: 25386066
[TBL] [Abstract][Full Text] [Related]
54. Rheumatologic diseases in patients with inborn errors of immunity in the USIDNET registry.
Padem N; Wright H; Fuleihan R; Garabedian E; Suez D; Cunningham-Rundles C; Marsh RA; Khojah A
Clin Rheumatol; 2022 Jul; 41(7):2197-2203. PubMed ID: 35099673
[TBL] [Abstract][Full Text] [Related]
55. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
[TBL] [Abstract][Full Text] [Related]
56. Infection-induced inflammation from specific inborn errors of immunity to COVID-19.
Ku CL; Chen IT; Lai MZ
FEBS J; 2021 Sep; 288(17):5021-5041. PubMed ID: 33971084
[TBL] [Abstract][Full Text] [Related]
57. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
Halmos T; Suba I
Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
[TBL] [Abstract][Full Text] [Related]
58. Viral Infections, the Microbiome, and Probiotics.
Harper A; Vijayakumar V; Ouwehand AC; Ter Haar J; Obis D; Espadaler J; Binda S; Desiraju S; Day R
Front Cell Infect Microbiol; 2020; 10():596166. PubMed ID: 33643929
[TBL] [Abstract][Full Text] [Related]
59. Characterisation and therapeutic manipulation of the gut microbiome in inflammatory bowel disease.
Schulberg J; De Cruz P
Intern Med J; 2016 Mar; 46(3):266-73. PubMed ID: 26968595
[TBL] [Abstract][Full Text] [Related]
60. Microbiota and Dose Response: Evolving Paradigm of Health Triangle.
Coleman M; Elkins C; Gutting B; Mongodin E; Solano-Aguilar G; Walls I
Risk Anal; 2018 Oct; 38(10):2013-2028. PubMed ID: 29900563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
